About two-thirds of Americans are getting too little or too much sleep, risking their health, a new study suggests.
Eli Lilly is seeking to further cement its stance as a leader in weight loss drugs in an ad campaign calling out “unapproved” medications.
In some ways, social media platforms are unlike traditional media platforms, such as radio and television. In other ways, ...
Rare Disease Day, an annual gathering hosted by the FDA and National Institutes of Health, was postponed. Medicare spending on 10 diabetes drugs, including popular GLP-1s, more than quadrupled over a ...
Eli Lilly LLY announced that it is increasing its manufacturing capacity in the United States by building four new plants.
Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the ...
Verve Therapeutics remains a high-reward investment despite setbacks. Click here to find out why VERV stock is a Buy.
The story has been updated to correct the new site locations At a press conference in Washington, D.C., Eli Lilly And Co ...
While attention has been on Apple’s progress (or lack thereof) in Research Triangle Park, the company continues to spend on a ...
The approval of etanercept for juvenile idiopathic arthritis in 1999 heralded a new era for children with arthritis. However, ...
Eli Lilly is making a massive $50 billion investment in U.S. manufacturing. This move more than doubles their previous $23 ...
Eli Lilly announced plans to invest $27 billion in four new manufacturing sites in the United States. The pharma giant also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results